These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7648217)

  • 1. The role of genetic factors in the development of end-stage renal disease.
    Freedman BI; Bowden DW
    Curr Opin Nephrol Hypertens; 1995 May; 4(3):230-4. PubMed ID: 7648217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans.
    Freedman BI; Yu H; Spray BJ; Rich SS; Rothschild CB; Bowden DW
    Kidney Int; 1997 Mar; 51(3):819-25. PubMed ID: 9067916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher risk for renal failure in first-degree relatives of white patients with end-stage renal disease: a population-based study.
    O'Dea DF; Murphy SW; Hefferton D; Parfrey PS
    Am J Kidney Dis; 1998 Nov; 32(5):794-801. PubMed ID: 9820449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report from the Caribbean renal registry, 2006.
    Soyibo AK; Barton EN
    West Indian Med J; 2007 Sep; 56(4):355-63. PubMed ID: 18198742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family history of end-stage renal disease among hemodialyzed patients in Poland.
    Gumprecht J; Zychma MJ; Moczulski DK; Gosek K; Grzeszczak W
    J Nephrol; 2003; 16(4):511-5. PubMed ID: 14696752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family history of end-stage renal disease among incident dialysis patients.
    Freedman BI; Soucie JM; McClellan WM
    J Am Soc Nephrol; 1997 Dec; 8(12):1942-5. PubMed ID: 9402097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes.
    Ma RC; Tam CH; Wang Y; Luk AO; Hu C; Yang X; Lam V; Chan AW; Ho JS; Chow CC; Tong PC; Jia W; Ng MC; So WY; Chan JC
    JAMA; 2010 Aug; 304(8):881-9. PubMed ID: 20736472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial aggregation of renal disease in a population-based case-control study.
    Lei HH; Perneger TV; Klag MJ; Whelton PK; Coresh J
    J Am Soc Nephrol; 1998 Jul; 9(7):1270-6. PubMed ID: 9644638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic factors in end-stage renal disease.
    Satko SG; Freedman BI; Moossavi S
    Kidney Int Suppl; 2005 Apr; (94):S46-9. PubMed ID: 15752239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of birth weight on familial aggregation of end-stage renal disease.
    Fan ZJ; Lackland DT; Kenderes B; Krisher J; Freedman BI
    Am J Nephrol; 2003; 23(2):117-20. PubMed ID: 12481151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease.
    Lovati E; Richard A; Frey BM; Frey FJ; Ferrari P
    Kidney Int; 2001 Jul; 60(1):46-54. PubMed ID: 11422735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.
    Wakai K; Nakai S; Kikuchi K; Iseki K; Miwa N; Masakane I; Wada A; Shinzato T; Nagura Y; Akiba T
    Nephrol Dial Transplant; 2004 Aug; 19(8):2044-52. PubMed ID: 15173379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etiology of End-Stage Renal Disease and Arterial Stiffness among Hemodialysis Patients.
    El Ghoul B; Daaboul Y; Korjian S; El Alam A; Mansour A; Hariri E; Samad S; Salameh P; Dahdah G; Blacher J; Safar ME; Aoun Bahous S
    Biomed Res Int; 2017; 2017():2543262. PubMed ID: 28299320
    [No Abstract]   [Full Text] [Related]  

  • 15. An improved understanding of the causes of end-stage renal disease.
    Young EW
    Semin Nephrol; 1997 May; 17(3):170-5. PubMed ID: 9165646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease.
    Babel N; Gabdrakhmanova L; Hammer MH; Schoenemann C; Skrypnikov V; Poliak N; Volk HD; Reinke P
    J Nephrol; 2006; 19(6):802-7. PubMed ID: 17173255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002.
    Stewart JH; McCredie MR; Williams SM; Jager KJ; Trpeski L; McDonald SP;
    Nephrology (Carlton); 2007 Oct; 12(5):520-7. PubMed ID: 17803478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for subclinical nephropathy in relatives of dialysis patients.
    Satko SG; Freedman BI
    Semin Dial; 2001; 14(5):311-3. PubMed ID: 11679093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of renin-angiotensin-aldosterone system gene polymorphisms and hypertension-induced end-stage renal disease in autosomal dominant polycystic kidney disease.
    Ramanathan G; Elumalai R; Periyasamy S; Lakkakula B
    Iran J Kidney Dis; 2014 Jul; 8(4):265-77. PubMed ID: 25001132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticipation of end stage renal disease in patients with autosomal dominant polycystic kidney disease in successive generations.
    Sotirakopoulos N; Tsitsios T; Stambolidou M; Cristodoulidou C; Spaia S; Mavromatidis K
    Ren Fail; 2001 Sep; 23(5):715-20. PubMed ID: 11725918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.